Characterization of inhibitory anti-Duffy binding protein II immunity: approach to Plasmodium vivax vaccine development in Thailand.
Plasmodium vivax Duffy binding protein region II (DBPII) is an important vaccine candidate for antibody-mediated immunity against vivax malaria. A significant challenge for vaccine development of DBPII is its highly polymorphic nature that alters sensitivity to neutralizing antibody responses. Here,...
Main Authors: | Patchanee Chootong, Tasanee Panichakul, Chongrak Permmongkol, Samantha J Barnes, Rachanee Udomsangpetch, John H Adams |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3338783?pdf=render |
Similar Items
-
Plasmodium vivax invasion of human erythrocytes inhibited by antibodies directed against the Duffy binding protein.
by: Brian T Grimberg, et al.
Published: (2007-12-01) -
Cross-reactive inhibitory antibody and memory B cell responses to variant strains of Duffy binding protein II at post-Plasmodium vivax infection
by: Pongsakorn Thawornpan, et al.
Published: (2022-01-01) -
Cross-reactive inhibitory antibody and memory B cell responses to variant strains of Duffy binding protein II at post-Plasmodium vivax infection.
by: Pongsakorn Thawornpan, et al.
Published: (2022-01-01) -
Characterization of Duffy Binding Protein II-specific CD4 +T cell responses in Plasmodium vivax patients
by: Pongsakorn Thawornpan, et al.
Published: (2023-05-01) -
Strain-Transcending Inhibitory Antibodies against Homologous and Heterologous Strains of Duffy Binding Protein region II.
by: Sudarat Wongkidakarn, et al.
Published: (2016-01-01)